[email protected]
  • LinkedIn
Procyon Technologies
  • Home
  • About Us
  • Contact Us
  • News
Select Page

Type 1 Diabetes Research at the University of Arizona

by Editor | Oct 4, 2019 | Diabetes, Procyon-Technologies News

Dr. Kowalski, JDFR president and CEO, recognized research being done by Dr. Klearchos Papas and Dr. Robert Johnson. Drs. Papas and Johnson are with the University of Arizona in Tucson, and are developing groundbreaking cell therapies to cure T1D through two projects:...

Islet Cell Containing Implantable Device in Development Releases Insulin in Response to Glucose Levels

by Editor | Oct 2, 2019 | Diabetes, Procyon-Technologies News

Unfortunately insulin shots, pens and pumps fail to perfectly manage blood sugar in many children, which may lead to long-term complications. For the last two decades, Dr. Papas has been working on a solution to this problem. In collaboration with other scientists...

Oxygen Critical to Practical Islet Transplants

by Editor | Oct 2, 2019 | Diabetes, Procyon-Technologies News

On April 2, 2019, Insulin Nation published an article about teams from the Universities of Arizona and Minnesota collaborating and on Klearchos Papas, PhD about his oxygen generator-based islet ‘tea bag’ transplant device. See Oxygen Critical to Practical Islet...

Implantable Device in Development Releases Insulin for Children with Diabetes

by Editor | Oct 1, 2019 | Diabetes, Procyon-Technologies News

Dr. Papas and his team developed a technology that allows insulin producing islet cells to be surgically implanted in the body

Health Watch: Device Allows Insulin Into Cells

by Editor | Sep 22, 2019 | Diabetes, Procyon-Technologies News

A Health Watch report, Tea Bag Insulin, by Margot Kim was posted September 21, 2019 by ABC 30 Action News, covering a device developed by Kearchos Papas, Ph.D, and his team at the University of Arizona that allows glucose to go into cells, and islet cells can sense it...
« Older Entries
Next Entries »

Procyon Technologies News

  • Procyon Technologies, St. Vincent’s Institute, and Cynata Therapeutics team up on heart repair therapy
  • Diabetes Cell Therapies Take Evasive Action
  • Health Sciences Researchers Close In on Diabetes Solution
  • Assessment of Islet Quality Pre-Transplant by Klearchos Papas, Ph.D.
  • Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
  • Type 1 Diabetes Research at the University of Arizona
  • Islet Cell Containing Implantable Device in Development Releases Insulin in Response to Glucose Levels
  • Oxygen Critical to Practical Islet Transplants
  • Implantable Device in Development Releases Insulin for Children with Diabetes
  • Health Watch: Device Allows Insulin Into Cells
procyon-star-sm

Located in Tucson, Arizona

Email: [email protected]

©2023 Procyon Technologies LLC, All Rights Reserved


Privacy Statement
  • Home
  • About Us
  • Contact Us
  • News
  • Klearchos Papas, Ph.D., Founder
  • Robert C. Johnson, Ph.D.
  • Thomas Loudovaris, Ph.D.
  • Julia Greenstein, Ph.D.
  • LinkedIn